Peter W. Glunz

1.6k total citations
31 papers, 1.3k citations indexed

About

Peter W. Glunz is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Peter W. Glunz has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 15 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Peter W. Glunz's work include Carbohydrate Chemistry and Synthesis (11 papers), Glycosylation and Glycoproteins Research (10 papers) and Chemical Synthesis and Analysis (6 papers). Peter W. Glunz is often cited by papers focused on Carbohydrate Chemistry and Synthesis (11 papers), Glycosylation and Glycoproteins Research (10 papers) and Chemical Synthesis and Analysis (6 papers). Peter W. Glunz collaborates with scholars based in United States, Germany and Sweden. Peter W. Glunz's co-authors include Samuel J. Danishefsky, Scott D. Kuduk, Jacob B. Schwarz, Dalibor Sameš, Lawrence J. Williams, Xiaotao Chen, Philip O. Livingston, Govindaswami Ragupathi, Samuel Hintermann and Valery Kudryashov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Peter W. Glunz

30 papers receiving 1.2k citations

Peers

Peter W. Glunz
Lisa A. Marcaurelle United States
Charles K. Marlowe United States
Gregory C. Adam United States
Stephen P. Hale United States
Michiel A. Leeuwenburgh Netherlands
Bryan Lanning United States
Andrzej Zatorski United States
Judd Berman United States
Martin Haraldsson Sweden
Landon R. Whitby United States
Lisa A. Marcaurelle United States
Peter W. Glunz
Citations per year, relative to Peter W. Glunz Peter W. Glunz (= 1×) peers Lisa A. Marcaurelle

Countries citing papers authored by Peter W. Glunz

Since Specialization
Citations

This map shows the geographic impact of Peter W. Glunz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Glunz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Glunz more than expected).

Fields of papers citing papers by Peter W. Glunz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Glunz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Glunz. The network helps show where Peter W. Glunz may publish in the future.

Co-authorship network of co-authors of Peter W. Glunz

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Glunz. A scholar is included among the top collaborators of Peter W. Glunz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Glunz. Peter W. Glunz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Zilun, Doree Sitkoff, Peter W. Glunz, et al.. (2023). Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitors. Bioorganic & Medicinal Chemistry Letters. 88. 129304–129304. 2 indexed citations
2.
3.
Glunz, Peter W.. (2017). Recent encounters with atropisomerism in drug discovery. Bioorganic & Medicinal Chemistry Letters. 28(2). 53–60. 224 indexed citations
4.
Wurtz, Nicholas R., Brandon L. Parkhurst, Peter W. Glunz, et al.. (2017). Neutral macrocyclic factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(12). 2650–2654. 5 indexed citations
5.
Ladziata, Vladimir, Peter W. Glunz, Yan Zou, et al.. (2016). Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(20). 5051–5057. 6 indexed citations
6.
Zhang, Xiaojun, Peter W. Glunz, James A. Johnson, et al.. (2016). Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex. Journal of Medicinal Chemistry. 59(15). 7125–7137. 16 indexed citations
7.
Glunz, Peter W., Xuhong Cheng, Daniel L. Cheney, et al.. (2015). Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(10). 2169–2173. 8 indexed citations
8.
Zhang, Xiaojun, Peter W. Glunz, Wen Jiang, et al.. (2013). Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(6). 1604–1607. 7 indexed citations
9.
Glunz, Peter W., Xiaojun Zhang, Yan Zou, et al.. (2013). Nonbenzamidine acylsulfonamide tissue factor–factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(18). 5244–5248. 13 indexed citations
10.
Zhang, Xiaojun, Peter W. Glunz, Yan Zou, et al.. (2013). Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors. ACS Medicinal Chemistry Letters. 5(2). 188–192. 15 indexed citations
11.
Martin, Scott, Peter W. Glunz, Brett R. Beno, et al.. (2011). The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(10). 2869–2872. 11 indexed citations
12.
Glunz, Peter W., Brent Douty, & Carl P. Decicco. (2003). Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(5). 785–788. 18 indexed citations
13.
Ragupathi, Govindaswami, Don M. Coltart, Lawrence J. Williams, et al.. (2002). On the power of chemical synthesis: Immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines. Proceedings of the National Academy of Sciences. 99(21). 13699–13704. 88 indexed citations
14.
Coltart, Don M., Ajay K. Royyuru, Lawrence J. Williams, et al.. (2002). Principles of Mucin Architecture:  Structural Studies on Synthetic Glycopeptides Bearing Clustered Mono-, Di-, Tri-, and Hexasaccharide Glycodomains. Journal of the American Chemical Society. 124(33). 9833–9844. 153 indexed citations
15.
Williams, Lawrence J., Christina R. Harris, Peter W. Glunz, & Samuel J. Danishefsky. (2000). In pursuit of an anticancer vaccine: a monomolecular construct containing multiple carbohydrate antigens. Tetrahedron Letters. 41(49). 9505–9508. 8 indexed citations
16.
Bohacek, Regine S., et al.. (1999). Exploring the Universe of Organic Molecules for Potent New Drugs. TechConnect Briefs. 35–37.
17.
18.
Glunz, Peter W., Lifeng He, Susan Band Horwitz, et al.. (1999). The synthesis and evaluation of 12,13-benzodesoxyepothilone B: a highly convergent route. Tetrahedron Letters. 40(38). 6895–6898. 13 indexed citations
19.
Rich, Daniel H., Regine S. Bohacek, Natalie A. Dales, Peter W. Glunz, & Amy S. Ripka. (1997). Transformation of Peptides into Non-Peptides. Synthesis of Computer-Generated Enzyme Inhibitors. CHIMIA International Journal for Chemistry. 51(1-2). 45–45. 12 indexed citations
20.
Perry, John, et al.. (1992). The Semipermeable surface, a new restricted access medium. Journal of Liquid Chromatography. 15(8). 1361–1379. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa A. Marcaurelle Breakdown of academic impact, for papers by Charles K. Marlowe Breakdown of academic impact, for papers by Gregory C. Adam Breakdown of academic impact, for papers by Stephen P. Hale Breakdown of academic impact, for papers by Michiel A. Leeuwenburgh Breakdown of academic impact, for papers by Bryan Lanning Breakdown of academic impact, for papers by Andrzej Zatorski Breakdown of academic impact, for papers by Judd Berman Breakdown of academic impact, for papers by Martin Haraldsson Breakdown of academic impact, for papers by Landon R. Whitby
Rankless by CCL
2026